Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424580
Status:
COMPLETED
Last Update Posted:
2008-01-23
First Post:
2007-01-18
Brief Title:
Airway Responses to Montelukast and Desloratadine
Sponsor:
University of Saskatchewan
Organization:
University of Saskatchewan
Study Overview
Official Title:
Airway Responses to Montelukast and Desloratadine
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Montelukast for asthma and desloratadine for allergies are effective therapy for their current uses Part of what happens when your allergies trigger your asthma should be prevented by either of these drugs This project is being conducted to determine if these drugs are effective either alone or in combination on controlling asthma that is triggered by allergies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None